Pharma Medica Research To Set up First U.S. Facility in St. Charles, MO

Toronto, Canada-based Pharma Medica Research, Inc. (PMRI) announced plans to set up their first U.S. manufacturing facility in St. Charles, Missouri.

Missouri Bioscience

Missouri Bioscience (photo – mo.gov)

The company will make a capital investment of $30.8 million, and is expected to create 320 new jobs.

Pharma Medica Research is a contract research organization that does R&D work and clinical trials for pharmaceutical companies.

Their head office is in Mississauga, Ontario and their Phase I clinical facility is in Toronto. The company is expanding their drug trial operations, and will expand into a space in St. Charles formerly used by a clinical research firm.

Missouri Gov. Jay Nixon met with the company’s executives in Chicago during the 2013 International BIO Convention.

Mohammed Bouhajib of Pharma Medica Research Inc. cited proximity to major pharmaceutical companies, the quality workforce and the favorable business climate as key factors that helped them decide to make the move to Missouri.

Not to mention more than $4 million in incentives offered by Missouri under the state’s Quality Jobs Program, which is a performance-based incentive provided based on fulfillment of job creation and investment commitments.

Bouhajib added that with the new research center in Missouri, the company would be able to compete in the global market and accommodate more clients.

St. Charles Mayor Sally Faith said they were delighted to have Pharma Medica Research join the city’s business community, and added that the company’s presence in the clinical research sector would further strengthen and diversify the city’s workforce and bolster economic development by creating jobs.

Joe Reagan, president and CEO of the St. Louis Regional Chamber, said the Chamber was pleased to partner with the Missouri Department of Economic Development, Missouri Partnership, and the City of St. Charles on this project.

Reagan added that bioscience was one of the industries in which the St. Louis region has an authentic strength.

Gov. Nixon likewise said that the substantial investment by Pharma Medica Research will further strengthen Missouri’s position as a bioscience leader.

Missouri has more than 4,000 companies in the bioscience, life sciences and agribusiness sectors.

Leave a Reply

Your email address will not be published. Please enter your name, email and a comment.